Related Experiment Video

Updated: Aug 24, 2026

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Stroke in Patients with Systemic Lupus Erythematosus and Antiphospholipid Antibody Syndrome

Claudia J. Chaves1

  • 1Lahey Clinic, 41 Mall Road.

Current Treatment Options in Cardiovascular Medicine
|April 21, 2004
PubMed

Insights

Primary stroke prevention in antiphospholipid antibody (APL) patients, especially with lupus, remains unclear. Individualized treatment is advised, prioritizing anticoagulation for high-risk APL features and secondary stroke prevention in antiphospholipid syndrome (APS).

Area of Science:

  • Cardiology
  • Rheumatology
  • Neurology

Background:

  • Primary stroke prevention strategies for patients with antiphospholipid antibodies (APLs), with or without systemic lupus erythematosus (SLE), are not well-established.
  • The management of SLE patients with valvular heart disease also lacks clear guidelines.
  • Individualized treatment decisions are necessary pending further research.

Purpose of the Study:

  • To review current understanding and provide guidance on the primary and secondary prevention of strokes in patients with antiphospholipid antibodies (APLs) and related conditions.
  • To highlight specific patient groups requiring special consideration for antithrombotic therapy.

Main Methods:

  • Review of existing literature and clinical guidelines regarding antiphospholipid antibodies (APLs), systemic lupus erythematosus (SLE), and stroke prevention.
  • Analysis of risk factors and treatment considerations for primary and secondary stroke prevention in affected patient populations.

Main Results:

  • Special consideration for preventive antithrombotic treatment is recommended for patients with persistent high titers of immunoglobulin G APLs requiring protein cofactors, lupus anticoagulant, or left-sided cardiac valve lesions.
  • High-level oral anticoagulation with warfarin is the preferred secondary stroke prevention strategy for antiphospholipid antibody syndrome (APS), with or without SLE or cardiac valvular lesions.
  • Immunosuppression is indicated only for active SLE disease, not for primary APS.

Conclusions:

  • Current evidence necessitates individualized treatment approaches for stroke prevention in APL and SLE patients.
  • Future research focusing on unique APL features associated with thrombosis risk may lead to more rational and targeted preventive strategies.
  • Warfarin remains the gold standard for secondary stroke prevention in APS, while immunosuppression is reserved for active SLE.

More Related Videos

Simultaneous Photothrombosis and Fiber Photometry to Induce and Monitor Ischemic Stroke in Behaving Mice07:49

Simultaneous Photothrombosis and Fiber Photometry to Induce and Monitor Ischemic Stroke in Behaving Mice

Published on: November 14, 2025

Related Concept Videos

Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...